Lenvatol 4mg Capsule is a targeted therapy medication used in the treatment of certain types of cancer. Its active ingredient is Lenvatinib, a multi-targeted receptor tyrosine kinase inhibitor. Lenvatinib works by blocking the activity of specific proteins that are involved in tumor growth, blood vessel formation (angiogenesis), and cancer progression. By inhibiting these pathways, Lenvatinib helps to slow down or stop the growth of cancer cells and can reduce the size of tumors.
Lenvatol 4mg Capsule is primarily indicated for the treatment of unresectable hepatocellular carcinoma (HCC), a type of liver cancer, and differentiated thyroid cancer that is refractory to radioactive iodine treatment. The typical dosage is 4mg taken orally once daily, but this can vary based on the specific cancer type and the patient’s response. It is crucial to take Lenvatol exactly as prescribed by your healthcare provider. Common side effects may include fatigue, diarrhea, decreased appetite, weight loss, hypertension, and proteinuria. Serious side effects can occur, so it is important to report any new or worsening symptoms to your doctor immediately. Store Lenvatol 4mg Capsules at room temperature, away from moisture and heat, and keep out of reach of children.
